Importantly, GPER has been shown to regulate body weight and glucose/lipid homeostasis and its activation exerts anti-obesity and anti-diabetic effects in multiple murine models, making it a potential therapeutic target for treating obesity and/or diabetes [25]. Here, GPER1 is linked to obesity due to melanocortin 4 receptor deficiency.